Brain tumour patients and COVID-19 vaccines: IBTA international survey

The International Brain Tumour Alliance (IBTA) is running a new survey on COVID-19 vaccines and brain tumour patients. The survey is for people over the age of 18 who have been diagnosed with any type of brain tumour (including metastatic brain tumours). The survey will collect data anonymously on, for example, how the coronavirus vaccination programmes in different countries have been offered to brain tumour patients; COVID-19 testing; which vaccines brain tumour patients have received; and vaccine side effects in brain tumour patients, etc.

The survey typically takes no more than ten minutes to complete and is available in eight languages:

English: https://www.research.net/r/IBTACOVIDVAX
French: https://www.research.net/r/IBTACOVIDVAX?lang=fr
German: https://www.research.net/r/IBTACOVIDVAX?lang=de
Italian: https://www.research.net/r/IBTACOVIDVAX?lang=it
Japanese:  https://www.research.net/r/IBTACOVIDVAX?lang=ja
Polish:  https://www.research.net/r/IBTACOVIDVAX?lang=pl
Spanish: https://www.research.net/r/IBTACOVIDVAX?lang=es
Urdu: https://www.research.net/r/IBTACOVIDVAX-ur

The deadline for submitting survey responses is 31^st August 2021.